Erytech Pharma S.A. buy melinda
Start price
29.12.17
/
50%
€18.70
Target price
02.07.18
€28.00
Performance (%)
-48.45%
End price
02.07.18
€9.64
Summary
This prediction ended on 02.07.18 with a price of €9.64. Massive losses of -48.45% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
According to melinda what are the pros and cons of Erytech Pharma S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Erytech Pharma S.A. diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 08/01 Präsentation
- ERYTECH ausgewählt , um den Dreifach - negativen Brustkrebs als neue Indikation für éryaspase
13 Apr 18
Globe
Im Auftrag von ihr verwalteten Investmentfonds, sagte der BVF Partners LP Unternehmen , dass es am 20. Dezember die Schwelle von 5% des Kapitals ERYTECH Pharma und halten im Namen erhöht hatte der Mittel sagte, 925.000 Aktien wie viele Stimmrechte vertreten, was 5,16% des Kapitals und 4,75% der Stimmrechte an der Gesellschaft.
(Laufzeit überschritten)
Stopped prediction by melinda for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
19.11.21
19.11.21
€2.60
19.11.22
19.11.22
-69.80%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
17.11.21
17.11.21
€1.80
17.11.22
17.11.22
0.00%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€3.12
17.03.20
17.03.20
€9.00
04.11.21
04.11.21
-28.37%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€22.14
15.11.17
15.11.17
€28.00
20.12.17
20.12.17
-28.73%
20.12.17
20.12.17
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€26.47
09.09.17
09.09.17
€29.50
15.11.17
15.11.17
-13.34%
15.11.17
15.11.17
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€26.47
09.09.17
09.09.17
€29.50
15.11.17
15.11.17
-13.34%
15.11.17
15.11.17
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€22.42
17.03.16
17.03.16
€30.00
19.09.16
19.09.16
-13.65%
19.09.16
19.09.16
Could be worthwhile Investment >10% per year